tripleplayvideopoker| [Research Express] Jingwei Hengrun received surveys from many institutions such as Changsheng Fund

Intro: Jingwei Hengrun released news on May 15. On May 14, the company received surveys from Changsheng Fund and other institutions. The rece...

Jingwei Hengrun released news on May 15. On May 14, the company received surveys from Changsheng Fund and other institutions. The receptionist was Zheng Hongju, Secretary of the Board of Directors, and the reception was in Beijing.

Main content of the survey

1. What are the main increases in revenue from the automotive electronics business that the company expects in 2024tripleplayvideopoker? Answer:① For the body domain controller project, a customer project has been mass-produced in 2024. The bicycle value of this product exceeds 2,000 yuan, and the volume of this project is expected to be higher. In addition, this product is expected to still have its own products this year.tripleplayvideopokerMass production of his customer projects; ②5G T-BOX products, the company has been targeted by multiple customer projects and is expected to have higher revenue in 2024; ③AD…

List of recipients

Institutional research and backtesting

In addition to the same day, Jingwei Hengrun has received a total of 477 surveys from 413 institutions in the past year. The survey and back-testing status in the past ten announcement days is shown in the following table:

Institutional research and backtesting in the past year

tripleplayvideopoker| [Research Express] Jingwei Hengrun received surveys from many institutions such as Changsheng Fund

Notes: 1. In this paper, the market adjustment model is selected to calculate the excess return rate, using the Shanghai and Shenzhen 300 Index as the benchmark index, and the excess return rate = real rate of return-benchmark rate of return;2. "Recent year" refers to the recent year as of the latest announcement date.

Market institution research

On May 15, Industrial Fulian, Guansheng Co., Ltd., Zhongcontrol Technology, Huiyu Pharmaceutical and other companies successively issued institutional research announcements. The details are as follows:

Survey of Shanghai and Shenzhen institutions

Disclaimer: This article is based on big data production and is for reference only. It does not constitute any investment advice. Therefore, the operation risks are at your own risk.

Comments